<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>2C-B-FLY - Complete Profile</title>
    <link rel="stylesheet" href="/Dyo-s-Dubious-Domain/style.css">
    <script>
        // Set base path for JavaScript files to use
        window.SITE_BASE_PATH = '/Dyo-s-Dubious-Domain/';
    </script>
</head>

<body class="
  
  
  
  ">
    <header class="page-header">
  <div class="container">
    <div class="page-header__content">
      <div class="logo-container">
        <a href="/Dyo-s-Dubious-Domain/" class="site-title">Dyo's Dubious Domain</a>
      </div>
      
      <nav>
        <ul role="list" class="nav-list flex-group">
          <li>
            <a href="/Dyo-s-Dubious-Domain/">Home</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/dyos-domain/">Dyo's Domain</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/about/">About</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/profile/">My Profile</a>
          </li>
         
        </ul>
      </nav>
    </div>
    
    <!-- Search Bar - Now underneath header -->
    <div class="search-container">
      <input type="text" id="search-input" placeholder="Search substances..." class="search-input" />
      <div id="search-results" class="search-results" style="display: none;"></div>
    </div>
  </div>
</header>

    <main>
      
<div class="substance-profile-header">
  <div class="container">
    <nav class="breadcrumb">
      <a href="/dyos-domain/">Dyo's Domain</a> ‚Üí <a href="/dyos-domain/psychedelics/">Psychedelics</a> ‚Üí <span>2C-B-FLY</span>
    </nav>
    
    <div class="substance-hero">
      <div class="substance-info">
        <h1>ü¶ã 2C-B-FLY</h1>
        <h2 class="chemical-name">2-(8-bromo-2,3,6,7-tetrahydrobenzo[1,2-b:4,5-b']difuran-4-yl)ethanamine</h2>
        
        <!-- Add to Profile Button -->
        <button id="add-to-profile-btn" class="add-to-profile-btn not-in-profile" 
                data-substance="2C-B-FLY" 
                data-category="Psychedelics" 
                data-chemical="2-(8-bromo-2,3,6,7-tetrahydrobenzo[1,2-b:4,5-b']difuran-4-yl)ethanamine">
          + Add to My Profile
        </button>
        
        <div class="alternative-names">
          <h3>Alternative Names & Slang</h3>
          <div class="names-grid">
            <span class="alt-name">2C-B-FLY</span>
            <span class="alt-name">2CBFly</span>
            <span class="alt-name">2CB-FLY</span>
            <span class="alt-name">Bromo-benzodifuranyl-ethylamine</span>
            <span class="alt-name">Bromo-FLY</span>
            <span class="alt-name">B-FLY</span>
            <span class="alt-name">The Butterfly</span>
            <span class="alt-name">FLY-2C-B</span>
            <span class="alt-name">BBDF-2EtAm</span>
            <span class="alt-name">Tetrahydrobenzodifuran</span>
            <span class="alt-name">BZ-FLY</span>
            <span class="alt-name">2C-Butterfly</span>
            <span class="alt-name">Wing</span>
            <span class="alt-name">Benzofuran-Fly</span>
            <span class="alt-name">Research Chemical RC</span>
            <span class="alt-name">Purple Butterfly</span>
          </div>
        </div>
        
        <div class="substance-meta-large">
          <span class="category psychedelic">Psychedelic</span>
          <span class="legal-status unscheduled">Unscheduled RC</span>
          <span class="duration very-long">12-18 hours</span>
        </div>
      </div>
      
      <div class="substance-visual">
        <div class="substance-image">
          <img src="/assets/substances/2c-b-fly.jpg" alt="2C-B-FLY powder and blotter" class="substance-photo">
        </div>
        <div class="molecule-structure">
          <div class="structure-placeholder">
            <p>2C-B-FLY Benzodifuran Structure</p>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>

<div class="container">
  
  <div class="profile-grid">
    
    <div class="profile-section identification">
      <h3>üîç Physical Identification</h3>
      <div class="identification-info">
        <div class="pure-form">
          <h4>Pure 2C-B-FLY</h4>
          <ul>
            <li><strong>Appearance:</strong> White to off-white crystalline powder</li>
            <li><strong>Texture:</strong> Fine crystalline structure, may be slightly sticky</li>
            <li><strong>Color:</strong> Pure white when fresh, may yellow with age/heat</li>
            <li><strong>Solubility:</strong> Moderately water-soluble, soluble in alcohol</li>
            <li><strong>Taste:</strong> Bitter, numbing sensation on tongue</li>
          </ul>
        </div>
        
        <div class="street-forms">
          <h4>Common Research Chemical Forms</h4>
          <ul>
            <li><strong>Powder:</strong> Most common form, requires precise milligram scales</li>
            <li><strong>Capsules:</strong> Pre-measured doses in gel caps</li>
            <li><strong>Blotter paper:</strong> Less common, usually higher concentrated</li>
            <li><strong>Liquid solutions:</strong> Dissolved in ethanol or propylene glycol</li>
          </ul>
        </div>
        
        <div class="adulterants-warning">
          <h4>‚ö†Ô∏è Research Chemical Risks</h4>
          <p><strong>Mislabeling:</strong> May be sold as 2C-B or other psychedelics</p>
          <p><strong>Contamination:</strong> Synthesis byproducts or unreacted starting materials</p>
          <p><strong>Dosage errors:</strong> Incorrect potency claims leading to overdose</p>
          <p><strong>Unknown analogues:</strong> Similar compounds with different effects/toxicity</p>
        </div>
      </div>
    </div>
    
    <div class="profile-section dosage">
      <h3>üíä Dosage Guidelines</h3>
      <div class="dosage-chart">
        <div class="dose-range threshold">
          <span class="range-label">Threshold</span>
          <span class="dose-amount">4-6mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range light">
          <span class="range-label">Light</span>
          <span class="dose-amount">6-10mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range common">
          <span class="range-label">Common</span>
          <span class="dose-amount">10-18mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range strong">
          <span class="range-label">Strong</span>
          <span class="dose-amount">18-25mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range heavy">
          <span class="range-label">Heavy/Dangerous</span>
          <span class="dose-amount">25mg+</span>
          <div class="dose-bar"></div>
        </div>
      </div>
      
      <div class="dosage-details">
        <h4>Critical Dosage Information</h4>
        <ul>
          <li><strong>Onset:</strong> 45-120 minutes (very slow, leads to redosing accidents)</li>
          <li><strong>Duration:</strong> 12-18 hours total experience</li>
          <li><strong>Peak:</strong> 3-6 hours after onset, very long plateau</li>
          <li><strong>Comedown:</strong> 6-12 hours gradual decline</li>
          <li><strong>Afterglow:</strong> Up to 24 hours of residual effects</li>
          <li><strong>Tolerance:</strong> Cross-tolerance with other phenethylamines</li>
        </ul>
      </div>
      
      <p class="dosage-note"><strong>CRITICAL WARNING:</strong> Very slow onset leads to accidental redosing and dangerous overdoses. Wait minimum 3 hours before considering additional dose.</p>
    </div>

    <div class="profile-section effects">
      <h3>‚ú® Effects Profile</h3>
      
      <div class="effects-timeline">
        <h4>Extended Timeline</h4>
        <div class="timeline-item">
          <span class="time">T+0:45-2:00</span>
          <span class="effect">Onset - subtle bodily sensations, mild visual changes</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+2:00-6:00</span>
          <span class="effect">Peak - intense visuals, altered perception, body high</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+6:00-12:00</span>
          <span class="effect">Plateau - sustained psychedelic effects, visual phenomena</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+12:00-18:00</span>
          <span class="effect">Comedown - gradual decline, residual stimulation</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+18:00-24:00</span>
          <span class="effect">Afterglow - mild residual effects, possible insomnia</span>
        </div>
      </div>

      <div class="effects-categories">
        <div class="effect-category positive">
          <h4>‚úÖ Positive Effects</h4>
          <ul>
            <li>Unique, colorful visual hallucinations and patterns</li>
            <li>Enhanced appreciation for music and art</li>
            <li>Mild euphoria and emotional enhancement</li>
            <li>Introspective and contemplative headspace</li>
            <li>Enhanced tactile sensations</li>
            <li>Creative thinking and problem-solving</li>
            <li>Sense of connectedness and empathy</li>
          </ul>
        </div>
        
        <div class="effect-category negative">
          <h4>‚ùå Negative Effects</h4>
          <ul>
            <li>Extremely long duration causing exhaustion</li>
            <li>Nausea and gastrointestinal discomfort</li>
            <li>Body load and physical tension</li>
            <li>Insomnia and difficulty sleeping post-trip</li>
            <li>Anxiety and paranoia at higher doses</li>
            <li>Vasoconstriction and circulation issues</li>
            <li>Potential for overwhelming visual experiences</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section pharmacology">
      <h3>üß† Pharmacology & Neuroscience</h3>
      <div class="pharma-details">
        <h4>Primary Mechanism of Action</h4>
        <p>2C-B-FLY is a potent partial agonist at serotonin 5-HT2A receptors, similar to other phenethylamine psychedelics. The benzodifuran ring system creates a rigid molecular structure that enhances receptor binding affinity and significantly extends the duration of action. It also shows activity at 5-HT2C receptors and moderate affinity for 5-HT1A receptors.</p>
        
        <h4>Detailed Receptor Pharmacology</h4>
        <div class="receptor-table">
          <div class="receptor-row">
            <span class="receptor">5-HT2A Receptor</span>
            <span class="activity">Partial Agonist (High Affinity)</span>
            <span class="effect">Visual hallucinations, altered perception</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">5-HT2C Receptor</span>
            <span class="activity">Partial Agonist</span>
            <span class="effect">Mood effects, appetite suppression</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">5-HT1A Receptor</span>
            <span class="activity">Moderate Affinity</span>
            <span class="effect">Anxiolytic effects, body sensations</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">Œ±1-Adrenergic</span>
            <span class="activity">Antagonist</span>
            <span class="effect">Vasoconstriction, cardiovascular effects</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">Dopamine D1</span>
            <span class="activity">Weak Affinity</span>
            <span class="effect">Minor stimulant-like effects</span>
          </div>
        </div>

        <h4>Metabolism & Pharmacokinetics</h4>
        <div class="metabolism-details">
          <p><strong>Absorption:</strong> Rapid oral absorption, peak plasma levels 2-4 hours</p>
          <p><strong>Metabolism:</strong> Hepatic metabolism via CYP enzymes, limited research on specific pathways</p>
          <p><strong>Half-life:</strong> Estimated 8-12 hours (long elimination phase)</p>
          <p><strong>Duration:</strong> 12-18 hours total effects</p>
          <p><strong>Bioavailability:</strong> High oral bioavailability (~80-90%)</p>
          <p><strong>Excretion:</strong> Primarily renal elimination of metabolites</p>
        </div>

        <h4>Structural Pharmacology</h4>
        <div class="neurotoxicity-info">
          <p><strong>Benzodifuran Structure:</strong> The fused ring system provides enhanced receptor binding and extended duration</p>
          <p><strong>Bromine Substitution:</strong> Increases potency and alters receptor selectivity profile</p>
          <p><strong>Conformational Rigidity:</strong> Ring fusion reduces molecular flexibility, enhancing receptor fit</p>
          <p><strong>Metabolic Stability:</strong> Ring system resists rapid metabolism, extending duration</p>
        </div>

        <h4>Unique Pharmacological Properties</h4>
        <ul>
          <li><strong>Extended Duration:</strong> Benzodifuran structure significantly prolongs effects vs. 2C-B</li>
          <li><strong>Visual Selectivity:</strong> Strong visual effects with less headspace confusion than classical psychedelics</li>
          <li><strong>Body Load:</strong> Notable physical sensations and vasoconstriction</li>
          <li><strong>Dose-Response:</strong> Steep dose-response curve requiring precise dosing</li>
          <li><strong>Tolerance:</strong> Cross-tolerance with other 5-HT2A agonists</li>
        </ul>
      </div>
    </div>

    <div class="profile-section safety">
      <h3>‚ö†Ô∏è Safety & Harm Reduction</h3>
      
      <div class="safety-grid">
        <div class="safety-item critical">
          <h4>üö® Critical Warnings</h4>
          <ul>
            <li><strong>Slow Onset:</strong> 45-120 minutes - high risk of accidental redosing</li>
            <li><strong>Very Long Duration:</strong> 12-18 hours requires full day commitment</li>
            <li><strong>Vasoconstriction:</strong> Can cause circulation problems and hypertension</li>
            <li><strong>Research Chemical:</strong> Limited safety data and unknown long-term effects</li>
            <li><strong>Dosage Sensitivity:</strong> Small increases in dose cause dramatic effect increases</li>
          </ul>
        </div>
        
        <div class="safety-item precautions">
          <h4>üõ°Ô∏è Safety Precautions</h4>
          <ul>
            <li><strong>Precise Dosing:</strong> Use analytical scale accurate to 0.1mg minimum</li>
            <li><strong>Set and Setting:</strong> Ensure safe, comfortable environment for 18+ hours</li>
            <li><strong>Trip Sitter:</strong> Have sober, experienced person present</li>
            <li><strong>No Redosing:</strong> Wait minimum 3 hours, preferably avoid entirely</li>
            <li><strong>Circulation Care:</strong> Stay warm, move regularly, monitor extremities</li>
            <li><strong>Hydration:</strong> Maintain fluid intake but don't overdrink</li>
          </ul>
        </div>
      </div>

      <div class="contraindications">
        <h4>üö´ Medical Contraindications</h4>
        <p><strong>Do not use if you have:</strong> Cardiovascular disease, hypertension, seizure disorders, psychiatric conditions, are taking psychiatric medications, or have family history of psychosis.</p>
      </div>
    </div>

    <div class="profile-section interactions">
      <h3>‚öóÔ∏è Drug Interactions</h3>
      
      <div class="interaction-levels">
        <div class="interaction dangerous">
          <h4>üî¥ Dangerous</h4>
          <ul>
            <li><strong>MAOIs:</strong> Potentially fatal serotonin syndrome</li>
            <li><strong>SSRIs/SNRIs:</strong> Reduced effects, possible serotonin syndrome</li>
            <li><strong>Stimulants:</strong> Dangerous cardiovascular stress and overheating</li>
            <li><strong>NBOMe Series:</strong> Extreme risk of seizures and death</li>
            <li><strong>DXM:</strong> Serotonin syndrome and dissociative complications</li>
          </ul>
        </div>
        
        <div class="interaction risky">
          <h4>üü° Risky</h4>
          <ul>
            <li><strong>Cannabis:</strong> May intensify anxiety and paranoid thoughts</li>
            <li><strong>Alcohol:</strong> Impaired judgment and increased accident risk</li>
            <li><strong>Other Psychedelics:</strong> Unpredictable interactions and extended duration</li>
            <li><strong>Tramadol:</strong> Serotonin syndrome risk</li>
          </ul>
        </div>
        
        <div class="interaction caution">
          <h4>üü† Use Caution</h4>
          <ul>
            <li><strong>Caffeine:</strong> May increase anxiety and vasoconstriction</li>
            <li><strong>Nicotine:</strong> Enhanced vasoconstriction effects</li>
            <li><strong>Blood Pressure Medications:</strong> Unpredictable cardiovascular effects</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section legal">
      <h3>‚öñÔ∏è Legal Status</h3>
      <div class="legal-info">
        <div class="legal-jurisdictions">
          <div class="jurisdiction">
            <h4>üá∫üá∏ United States</h4>
            <p>Unscheduled federally - legal gray area, may be prosecuted under Federal Analogue Act</p>
          </div>
          <div class="jurisdiction">
            <h4>üá¨üáß United Kingdom</h4>
            <p>Class A controlled substance under Psychoactive Substances Act</p>
          </div>
          <div class="jurisdiction">
            <h4>üá©üá™ Germany</h4>
            <p>Controlled under NpSG (New Psychoactive Substances Act)</p>
          </div>
          <div class="jurisdiction">
            <h4>üá¶üá∫ Australia</h4>
            <p>Prohibited substance - illegal to manufacture, import, or supply</p>
          </div>
        </div>
        
        <div class="therapeutic-status">
          <h4>üè• Research Status</h4>
          <p>Purely research chemical with no accepted medical use. Legal status varies widely and is changing rapidly. Always check local laws before considering acquisition or use.</p>
        </div>
      </div>
    </div>

    <div class="profile-section history">
      <h3>üìö History & Development</h3>
      
      <div class="history-timeline">
        <div class="history-event">
          <span class="year">1996</span>
          <p>First synthesized by Aaron Monte and reported in underground chemistry circles</p>
        </div>
        <div class="history-event">
          <span class="year">2000s</span>
          <p>Occasional reports in research chemical communities, limited availability</p>
        </div>
        <div class="history-event">
          <span class="year">2005-2010</span>
          <p>Increased synthesis and distribution through research chemical vendors</p>
        </div>
        <div class="history-event">
          <span class="year">2010-2015</span>
          <p>Growing popularity as 2C-B alternative with longer duration</p>
        </div>
        <div class="history-event">
          <span class="year">2015-2020</span>
          <p>Multiple countries begin scheduling 2C-B-FLY and related compounds</p>
        </div>
        <div class="history-event">
          <span class="year">2020+</span>
          <p>Continued underground use despite increasing legal restrictions</p>
        </div>
      </div>

      <div class="cultural-impact">
        <h4>Research Chemical Context</h4>
        <p>2C-B-FLY represents the evolution of psychedelic research chemicals - designed to extend and modify the effects of established compounds like 2C-B. Popular among experienced psychonauts seeking longer-duration visual experiences with less mental confusion than classical psychedelics.</p>
      </div>
    </div>

    <div class="profile-section research">
      <h3>üî¨ Current Research & Studies</h3>
      
      <div class="research-areas">
        <div class="research-item">
          <h4>Limited Academic Research</h4>
          <p>Very limited formal research due to legal status and recent development. Most data comes from user reports and basic pharmacological characterization.</p>
        </div>
        
        <div class="research-item">
          <h4>Receptor Binding Studies</h4>
          <p>Basic receptor binding profiles established, showing high 5-HT2A affinity and selectivity compared to classical psychedelics.</p>
        </div>
        
        <div class="research-item">
          <h4>Safety Concerns</h4>
          <p>Case reports of adverse effects including persistent vasoconstriction and potential cardiac complications in vulnerable individuals.</p>
        </div>
        
        <div class="research-item">
          <h4>Structural-Activity Studies</h4>
          <p>Research into benzodifuran modifications for developing therapeutic psychedelics with improved safety profiles.</p>
        </div>
      </div>
    </div>

  </div>

  <div class="substance-resources">
    <h3>üìñ Additional Resources</h3>
    <div class="resources-grid">
      <div class="resource-item">
        <h4>Harm Reduction</h4>
        <ul>
          <li><a href="https://www.erowid.org/">Erowid</a> - Experience reports and information</li>
          <li><a href="https://psychonautwiki.org/">PsychonautWiki</a> - Detailed pharmacological information</li>
          <li><a href="https://www.drugsdata.org/">DrugsData.org</a> - Substance testing results</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Safety Resources</h4>
        <ul>
          <li><a href="https://www.bluelight.org/">Bluelight</a> - Harm reduction community</li>
          <li><a href="https://rollsafe.org/">RollSafe.org</a> - Safer use guidelines</li>
          <li><a href="https://www.reddit.com/r/researchchemicals">r/ResearchChemicals</a> - User experiences and safety tips</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Crisis Support</h4>
        <ul>
          <li><a href="https://www.samhsa.gov/">SAMHSA</a> - Mental health crisis support</li>
          <li><a href="https://www.maps.org/">MAPS</a> - Psychedelic emergency support</li>
          <li><a href="https://firestone.org/">Firestone</a> - Psychedelic crisis support</li>
        </ul>
      </div>
    </div>
  </div>

</div>
    </main>
     <div class="footer-divider"></div>
<footer class="site-footer">
  
</footer>




<footer class="site-footer">
  
  </svg>
    <img src="/assets/logo.svg" alt="My Logo" class="logo">
     <p>¬© 2025 Uwaniumnya. Highly Illegal.</p>
  </footer>

  

    <!-- Search Scripts -->
    <script src="/Dyo-s-Dubious-Domain/js/lunr.min.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/search.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/substance-integration.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/profile.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/friends.js"></script>
</body>
</html>